CGM Management Guidelines and Indications
January 26, 2022

Experts in endocrinology review the updated ADA diabetes-management guidelines and highlight the inclusion of CGMs and the indications surrounding their use.

Glucose Management Considerations in Diabetes
January 26, 2022

Elena A. Christofides, MD, FACE, and David T. Ahn, MD, discuss the inherent challenges associated with blood glucose monitoring in patients with type 1 and 2 diabetes.

Painful Diabetic Neuropathy Treatment: A Guideline Topline
January 24, 2022

The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.

CGM-derived Time in Range Found Similar to A1c for Predicting Microvascular Complications in T2D
January 18, 2022

Use of continuous glucose monitoring to assess time in target glucose range in T2D patients was evaluated in a systematic literature review covering ~14 000 participants.

Obesity Expert Highlights 2021 Research Success, Looks to 2022 and Beyond
January 17, 2022

WATCH: The FDA approval of semaglutide 2.4 mg for adults with obesity was "by far the big event in 2021," said Donna Ryan, MD. More from our look back/look ahead interview, here.

American Diabetes Association Publishes Standards of Medical Care for 2022
January 04, 2022

The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.

Current Advances in Continuous Glucose Monitoring Technology
January 03, 2022

CGMs have revolutionized diabetes management for patients and healthcare providers alike. This slide show summarizes the most recent enhancements.

Continuous Glucose Monitoring for Type 2 Diabetes in Primary Care: 2021 Research Review
December 17, 2021

Continuous glucose monitoring for type 2 diabetes patients is gaining exposure in the literature with positive evidence accumulating. Examples follow.

Racial Disparities in Use of Diabetes Technology Widen among Medicare Enrollees
December 16, 2021

While use of insulin pumps and CGM increased over a 3-year study period for all racial-ethnic groups, the inequities were significant between White adults and all others.

Obesity Linked to Elevated Risk of Heart Failure in Persons with Diabetes
December 10, 2021

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.